<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Heat Biologics, Inc.

    Heat Biologics, Inc.

    Heat Biologics a biopharmaceutical company that develops immunotherapies with the ...

    Heat Biologics a biopharmaceutical company that...

    Filing Type:    PU
    Oracle Health, Inc.

    Oracle Health, Inc.

    Oracle Health is developing a Digital Health Insertable (Under The Skin) Cardiac D...

    Oracle Health is developing a Digital Health In...

    Amount Raised:    $182,002.00
    Fundraising Status:    EC
    Filing Type:    CF
    Patterson Companies, Inc.

    Patterson Companies, Inc.

    Patterson Companies Inc. (Nasdaq: PDCO) connects dental and animal health customer...

    Patterson Companies Inc. (Nasdaq: PDCO) connect...

    Filing Type:    PU
    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicat...

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI...

    Filing Type:    PU
    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncolo...

    Spectrum Pharmaceuticals is a leading biotechno...

    Filing Type:    PU
    Avid Bioservices, Inc.

    Avid Bioservices, Inc.

    Avid Bioservices is a dedicated contract development and manufacturing organizatio...

    Avid Bioservices is a dedicated contract develo...

    Filing Type:    PU
    Corcept Therapeutics Incorporated

    Corcept Therapeutics Incorporated

    Corcept is a pharmaceutical company engaged in the discovery, development and comm...

    Corcept is a pharmaceutical company engaged in ...

    Filing Type:    PU
    Chimerix, Inc.

    Chimerix, Inc.

    Chimerix is a development-stage biopharmaceutical company dedicated to acceleratin...

    Chimerix is a development-stage biopharmaceutic...

    Filing Type:    PU
    Cellular Biomedicine Group, Inc.

    Cellular Biomedicine Group, Inc.

    Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapie...

    Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)...

    Filing Type:    PU
    Forward Pharma A/S

    Forward Pharma A/S

    Forward Pharma A/S is a Danish biopharmaceutical company that commenced developmen...

    Forward Pharma A/S is a Danish biopharmaceutica...

    Filing Type:    PU
    Apellis Pharmaceuticals, Inc.

    Apellis Pharmaceuticals, Inc.

    We are a clinical-stage biopharmaceutical company focused on the development of no...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    ChemoCentryx, Inc.

    ChemoCentryx, Inc.

    ChemoCentryx is a biopharmaceutical company focused exclusively on discovering, de...

    ChemoCentryx is a biopharmaceutical company foc...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.